Lam Research Corporation
General ticker "LRCX" information:
- Sector: Information Technology
- Industry: Semiconductors
- Capitalization: $216.8B (TTM average)
Lam Research Corporation follows the US Stock Market performance with the rate: 72.6%.
Estimated limits based on current volatility of 2.4%: low 288.30$, high 302.60$
Factors to consider:
- Company included in S&P500 list
- Company included in NASDAQ-100 index
- Company pays dividends (quarterly): last record date 2026-06-17, amount 0.26$ (Y0.36%)
- Total employees count: 19000 (+8.9%) as of 2025
- China accounted for 42.2% of revenue in the fiscal year ended 2024-06-30
- US accounted for 7.4% of revenue in the fiscal year ended 2024-06-30
- Top business risk factors: Technological changes, Geopolitical risks, Market concentration, Acquisition/divestiture risks, Cybersecurity threats
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2026-06-28 to 2028-06-27
- 2026-06-28 to 2027-06-28 estimated range: [238.19$, 365.73$]
- 2027-06-28 to 2028-06-27 estimated range: [232.28$, 359.02$]
Financial Metrics affecting the LRCX estimates:
- Negative: with PPE of 66.5 at the end of fiscal year the price was high
- Positive: Operating profit margin, % of 35.29 > 18.77
- Negative: Industry operating profit margin (median), % of -3.49 <= 2.92
- Negative: -0.14 < Industry inventory ratio change (median), % of -0.14
- Negative: -0.75 < Inventory ratio change, % of -0.72
- Positive: Investing cash flow per share per price, % of -0.19 > -0.64
Short-term LRCX quotes
Relationship graph
Long-term LRCX plot with estimates
Financial data
| YTD | 2024-06-30 | 2025-06-29 | 2026-06-28 |
|---|---|---|---|
| Operating Revenue | $14,905.39MM | $18,435.59MM | $23,232.69MM |
| Operating Expenses | $10,641.47MM | $12,534.62MM | $15,032.90MM |
| Operating Income | $4,263.91MM | $5,900.97MM | $8,199.80MM |
| Non-Operating Income | $96.31MM | $57.16MM | $62.68MM |
| R&D Expense | $1,902.44MM | $2,096.39MM | $2,375.87MM |
| Income(Loss) | $4,360.22MM | $5,958.13MM | $8,262.47MM |
| Taxes | $532.45MM | $599.91MM | $997.08MM |
| Net Income(Loss)* | $3,827.77MM | $5,358.22MM | $7,265.40MM |
| Stockholders Equity | $8,539.45MM | $9,861.62MM | $12,470.92MM |
| Inventory | $4,217.92MM | $4,307.99MM | $4,276.11MM |
| Assets | $18,744.73MM | $21,345.26MM | $23,529.74MM |
| Operating Cash Flow | $4,652.27MM | $6,173.26MM | $5,857.66MM |
| Capital expenditure | $396.67MM | $759.19MM | $966.40MM |
| Investing Cash Flow | $-370.61MM | $-708.09MM | $-922.15MM |
| Financing Cash Flow | $-3,995.85MM | $-4,936.64MM | $-5,717.79MM |
| Earnings Per Share** | $2.91 | $4.17 | $5.79 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.